Net Loss per Share of Common Stock (Tables)

8 Months Ended

12 Months Ended

Sep. 30, 2024

Dec. 31, 2023

Net Loss per Share of Common Stock [Abstract]

Schedule of Diluted Net Loss per Share

The following table summarizes the number of shares of Common Stock issuable upon conversion or exercise, as applicable, of convertible securities, stock options, and warrants that were not included in the calculation of diluted net loss per share because such shares are antidilutive:

	September 30, 2024		September 30, 2023
	(Successor)		(Predecessor)
Conversion of convertible preferred stock issued and outstanding		847,701		17,995
Conversion of convertible preferred stock underlying convertible preferred stock warrants		497,977		1,192
Exercise of common warrants into common stock		183,054		-
Common stock reserved for employee stock option plan (ESPP)		5,272		-
Common stock underlying outstanding options		26,575		577
		1,560,579		19,764

The following table summarizes the number of shares of common stock issuable upon conversion or exercise, as applicable, of convertible securities, warrants and restricted stock that were not included in the calculation of diluted net loss per share because such shares are antidilutive:

	Year ended December 31,
	2023		2022
Common stock options		782,499		1,138,110
Convertible preferred stock		27,920,467		27,920,467
Convertible preferred warrants		1,849,638		1,849,638
		30,552,604		30,908,215